C57.4
Malignant neoplasm of uterine adnexa, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the uterine adnexa refers to cancerous growths that originate in the tissues surrounding the uterus, including the ovaries, fallopian tubes, and other nearby structures. The specific code C57.4 is used when the exact location of the tumor within these regions is unspecified. Uterine adnexal cancers are serious health conditions that require medical diagnosis and treatment. Recognizing the symptoms and understanding potential causes can be vital for early detection and management.
Causes & Symptoms
Clinical Causes: Genetic mutations that lead to abnormal cell growth Family history of ovarian or related cancers Hormonal imbalances influencing reproductive tissues Exposure to certain environmental toxins or carcinogens Age-related changes, particularly in postmenopausal women Personal history of other cancers or reproductive health issues
Key Symptoms: Pelvic or abdominal pain and discomfort Abnormal vaginal bleeding or discharge Bloating or swelling in the lower abdomen Persistent feeling of fullness or urinary urgency Unexplained weight loss or fatigue Pain during sexual intercourse
Diagnostic & Treatment
Diagnosis Path: Pelvic examinations to feel for abnormalities Imaging tests such as ultrasound, CT scan, or MRI to visualize the reproductive organs Blood tests to look for tumor markers that may indicate cancer activity Biopsy procedures to obtain tissue samples for histopathological analysis Laparoscopy to directly view the pelvic organs and possibly collect tissue samples
Treatment Protocols: Surgical removal of the tumor and affected tissues, which may involve hysterectomy and removal of the ovaries and fallopian tubes Chemotherapy to destroy cancer cells systemically Radiation therapy, used less frequently but in specific cases to target localized disease Targeted therapy aimed at specific molecular features of the cancer Hormonal therapy in selected cases if hormone receptors are involved
Clinical Advice & FAQs
Billing Guidance
Is C57.4 a billable ICD-10 code?
Yes, C57.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C57.4?
Clinical documentation must specify the nature of Malignant neoplasm of uterine adnexa, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference